MétaCan
Menu
Back to cohort
Record W4226003869 · doi:10.1093/jnci/djac094

Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk

2022· article· en· W4226003869 on OpenAlexafffund
Yu Tian, Andre E. Kim, Stephanie A. Bien, Yi Lin, Conghui Qu, Tabitha A. Harrison, Robert Carreras‐Torres, Virginia Díez‐Obrero, Niki Dimou, David A. Drew, Akihisa Hidaka, Jeroen R. Huyghe, Kristina M. Jordahl, John L. Morrison, Neil Murphy, Mireia Obón‐Santacana, Cornelia M. Ulrich, Jennifer Ose, Anita R. Peoples, Edward Ruiz-Narváez, Anna Shcherbina, Mariana C. Stern, Yu‐Ru Su, Fränzel J.B. van Duijnhoven, Volker Arndt, James W. Baurley, Sonja I. Berndt, D. Timothy Bishop, Hermann Brenner, Daniel D. Buchanan, Andrew T. Chan, Jane C. Figueiredo, Steven Gallinger, Stephen B. Gruber, Sophia Harlid, Michael Hoffmeister, Mark A. Jenkins, Amit D. Joshi, Temitope O. Keku, Susanna C. Larsson, Loı̈c Le Marchand, Li Li, Graham G. Giles, Roger L. Milne, Hongmei Nan, Rami Nassir, Shuji Ogino, Arif Budiarto, Elizabeth A. Platz, John D. Potter, Ross L. Prentice, Gad Rennert, Lori C. Sakoda, Robert E. Schoen, Martha L. Slattery, Stephen N. Thibodeau, Bethany Van Guelpen, Kala Visvanathan, Emily White, Alicja Wolk, Michael O. Woods, Anna H. Wu, Peter T. Campbell, Graham Casey, David V. Conti, Marc J. Gunter, Anshul Kundaje, Juan Pablo Lewinger, Vı́ctor Moreno, Polly A. Newcomb, Bens Pardamean, Duncan C. Thomas, Konstantinos K. Tsilidis, Ulrike Peters, W. James Gauderman, Li Hsu, Jenny Chang‐Claude

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2022
Typearticle
Languageen
FieldMedicine
TopicMenopause: Health Impacts and Treatments
Canadian institutionsMemorial University of NewfoundlandLunenfeld-Tanenbaum Research InstituteUniversity of TorontoMount Sinai Hospital
FundersNational Heart, Lung, and Blood InstituteSchool of Public Health, Imperial College LondonNIHR Imperial Biomedical Research CentreNational Health and Medical Research CouncilWorld Cancer Research FundNational Center for Advancing Translational SciencesMedical Research CouncilNational Institutes of HealthOffice of Research Infrastructure Programs, National Institutes of HealthJunta de Castilla y LeónInstitut Gustave-RoussyCancer Council VictoriaDeutsche KrebshilfeInstituto de Salud Carlos IIIXarxa de Bancs de Tumors de CatalunyaUniversitat de BarcelonaVetenskapsrådetMutuelle Générale de l'Education NationaleMinisterio de Economía y CompetitividadCanadian Institutes of Health ResearchCancerfondenKarolinska InstitutetInstitut National de la Santé et de la Recherche MédicaleUmeå UniversitetDeutsches KrebsforschungszentrumLigue Contre le CancerSwedish Cancer FoundationBundesministerium für Bildung und ForschungCanadian Cancer Society Research InstituteMcGill UniversityUniversity of LeedsDivision of Cancer Prevention, National Cancer InstituteNational Institute for Health and Care ResearchNational Cancer InstituteKnut och Alice Wallenbergs StiftelseFred Hutchinson Cancer Research CenterAssociazione Italiana per la Ricerca sul CancroImperial College LondonDamon Runyon Cancer Research FoundationGénome QuébecWorld Health OrganizationCancer Research UKU.S. Department of Health and Human Services
KeywordsOdds ratioMedicineInternal medicineProgestogenOncologyColorectal cancerSingle-nucleotide polymorphismConfidence intervalHormone therapyEstrogenGenotypeGenome-wide association studyGynecologyCancerBreast cancerGeneticsBiologyGene

Abstract

fetched live from OpenAlex

BACKGROUND: The use of menopausal hormone therapy (MHT) may interact with genetic variants to influence colorectal cancer (CRC) risk. METHODS: We conducted a genome-wide, gene-environment interaction between single nucleotide polymorphisms and the use of any MHT, estrogen only, and combined estrogen-progestogen therapy with CRC risk, among 28 486 postmenopausal women (11 519 CRC patients and 16 967 participants without CRC) from 38 studies, using logistic regression, 2-step method, and 2- or 3-degree-of-freedom joint test. A set-based score test was applied for rare genetic variants. RESULTS: The use of any MHT, estrogen only and estrogen-progestogen were associated with a reduced CRC risk (odds ratio [OR] = 0.71, 95% confidence interval [CI] = 0.64 to 0.78; OR = 0.65, 95% CI = 0.53 to 0.79; and OR = 0.73, 95% CI = 0.59 to 0.90, respectively). The 2-step method identified a statistically significant interaction between a GRIN2B variant rs117868593 and MHT use, whereby MHT-associated CRC risk was statistically significantly reduced in women with the GG genotype (OR = 0.68, 95% CI = 0.64 to 0.72) but not within strata of GC or CC genotypes. A statistically significant interaction between a DCBLD1 intronic variant at 6q22.1 (rs10782186) and MHT use was identified by the 2-degree-of-freedom joint test. The MHT-associated CRC risk was reduced with increasing number of rs10782186-C alleles, showing odds ratios of 0.78 (95% CI = 0.70 to 0.87) for TT, 0.68 (95% CI = 0.63 to 0.73) for TC, and 0.66 (95% CI = 0.60 to 0.74) for CC genotypes. In addition, 5 genes in rare variant analysis showed suggestive interactions with MHT (2-sided P < 1.2 × 10-4). CONCLUSION: Genetic variants that modify the association between MHT and CRC risk were identified, offering new insights into pathways of CRC carcinogenesis and potential mechanisms involved.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.003
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.050
GPT teacher head0.364
Teacher spread0.314 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicMenopause: Health Impacts and TreatmentsFrench-language works237,207